-

Hims & Hers Named D-To-C Brand of The Year By Ad Age

Company Honored for its Consumer-Centric Approach, Expansion of Health and Wellness Offerings During the Pandemic

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has been named D-To-C Brand of the Year by Ad Age, a premier publication for the advertising, marketing, and media industry, as part of the publication’s A-List & Creativity Awards 2021.

“Hims & Hers is designed to represent a new way, for a digitally native generation, to support health and wellness. It is no longer a one-product-fits-all scenario when it comes to healthcare,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “We are honored to be acknowledged for these efforts, particularly by such a prestigious group of advertisers and marketers, and to be among such well-known and creative household brands as honorees.”

The Creativity Awards honor “the biggest ideas of the year, the people who made them and other creative companies who are leading the way forward in marketing, business and technology. The winners were determined by juries comprising some of the industry’s brightest leaders, whom we selected based on their enduring and impactful contributions to advertising and marketing.”

In her coverage of the awards, associate creativity editor Alexandra Jardine wrote: “Digital healthcare came into its own when COVID-19 began to take its toll, and no one was more ready than telehealth brand Hims & Hers...The brand prides itself on its consumer-centric approach, from its user-friendly website to product display, and says it will continue to disrupt the healthcare system even as we come out of the pandemic.”

For more information, please visit www.forhims.com and www.forhers.com.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Linda O’Connor
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers has been named D-To-C Brand of The Year By Ad Age in the publication's A-List & Creativity Awards 2021.
Release Versions

Contacts

Linda O’Connor
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com. “More than 2.5 million subscribers now rely on us for a healthcare experience that is both accessible and deeply personal – and we believe we’re well on our way to becoming the global leade...

Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company’s ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia a...

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill with the same active ingredient as Wegovy®**. This needle-free treatment joins a full suite of weight loss solutions designed to meet the specific needs and preferences of individual customers. By leveraging nearly a decade of infrastructur...
Back to Newsroom